BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V

Investigator: Colin Barker, MD

Study Coordinator: LaShawna Green

Status: Enrolling

ClinicalTrials.gov Number: NCT02389946

Phone: 713.441.6548

IRB Number: Pro00012578

Description

The objective of this study is to assess the safety and efficacy of the Orsiro Sirolimus Eluting Coronary Stent System in the treatment of subjects with up to three native de novo or restenotic (standard PTCA only) coronary artery lesions compared to the Xience coronary stent system.
More to Explore